Ethyl Bromide → 1-ethyl-3-methyl-1,3,9,10,11,12-hexahydro-2H-quino[4,3,2-ef][1,4]benzoxazepin-2-one
반응식
[CH3:1][CH:2]1[C:8](=[O:9])[NH:7][C:6]2=[C:10]3[C:15](=[N:16][C:17]4=[CH:18][CH:19]=[CH:20][C:4](=[C:5]24)[O:3]1)[CH2:14][CH2:13][CH2:12][CH2:11]3.[CH3:21][C:22](C)([O-])C.[K+].BrCC>O1CCCC1>[CH2:21]([N:7]1[C:6]2=[C:10]3[C:15](=[N:16][C:17]4=[CH:18][CH:19]=[CH:20][C:4](=[C:5]24)[O:3][CH:2]([CH3:1])[C:8]1=[O:9])[CH2:14][CH2:13][CH2:12][CH2:11]3)[CH3:22]참가 물질
실험 절차
To a suspension of 1,3,9,10,11,12-hexahydro-3-methyl-2H-quino[4,3,2-ef][1,4]benzoxazepin-2-one (4.82 g) in dry tetrahydrofuran (150 ml) was added potassium tert-butoxide (2.42 g), with stirring. After 20 mins, bromoethane (5.37 ml) was added, and the reaction mixture was refluxed overnight. The reaction mixture was concentrated, diluted with saturated potassium carbonate solution, and extracted with ethyl acetate. The organic extracts were dried over anhydrous magnesium sulfate, concentrated, and the residue was adhered to silica and flash chromatographed (30% ethyl acetate/hexane). The appropriate fractions were concentrated. Trituration of the residue with diethyl ether/pentane (1/1) gave 4.51 g (85%) of 1-ethyl-3-methyl-1,3,9,10,11,12-hexahydro-2H-quino[4,3,2-ef][1,4]benzoxazepin-2-one.
후처리
- temperaturethe reaction mixture was refluxed overnight
- concentrationThe reaction mixture was concentrated
- additiondiluted with saturated potassium carbonate solution
- extractionextracted with ethyl acetate
- dry with materialThe organic extracts were dried over anhydrous magnesium sulfate
- concentrationconcentrated
- customchromatographed (30% ethyl acetate/hexane)
- concentrationThe appropriate fractions were concentrated
출처 및 근거
- ORD 기록
- ord-abf97870a96846bab7aab8093681537b
- 출처 데이터셋
- uspto-grants-1991_02
- 특허 번호
- US04994452
반응 노트
불러오는 중…